Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance

ADMA Biologics Inc
Invesco WilderHill Clean Energy ETF

Price performance

Price movement over the last 24 hours

Key statistics

ADMA Biologics Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? ADMA Biologics Inc trades at $9.22 (market cap $2.13B), while Invesco WilderHill Clean Energy ETF trades at $35.16. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAPBW
Market Cap
$2.13B
Sector
HealthSector/Thematic
52-Week High
$20.38$46.99
52-Week Low
$7.60$21.70
Enterprise Value
$2.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Invesco WilderHill Clean Energy ETF

PBW trades at $37.52, up 2.57% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF lacks key valuation metrics like P/E and P/S, and recent news highlights its volatility tied to interest rates and clean energy sector momentum. A dividend of $0.24 is scheduled for June 2026, but financial statements for the current period are unavailable.

The outlook is cautious due to bearish technicals and sensitivity to Treasury yields, though clean energy tailwinds from energy security concerns offer potential. Risks include rate cycle volatility and sector competition, with investor sentiment mixed amid Nasdaq pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Invesco WilderHill Clean Energy ETF

PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.

Read more on PBW